Evidence map›Paper›PMID 31012202›Full record

ArticleJournal of magnetic resonance imaging : JMRI2019

Probing demyelination and remyelination of the cuprizone mouse model using multimodality MRI.

Nian Wang, Jie Zhuang, Hongjiang Wei, Russell Dibb, Yi Qi, Chunlei Liu

Abstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Diffusion MRI reveals amyloid plaque-associated cellular signatures through spatial transcriptomic integration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nian WangCenter for in vivo Microscopy, Duke University, Durham, North Carolina, USA.ORCID 0000-0001-6547-8580
Jie ZhuangBrain Imaging and Analysis Center, Duke University, Durham, North Carolina, USA.
Hongjiang WeiBrain Imaging and Analysis Center, Duke University, Durham, North Carolina, USA.
Russell DibbCenter for in vivo Microscopy, Duke University, Durham, North Carolina, USA.
Yi QiCenter for in vivo Microscopy, Duke University, Durham, North Carolina, USA.
Chunlei LiuDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, California, USA.ORCID 0000-0001-8816-4832

Funding

INTEGRATED CENTER FOR IN VIVO MICROSCOPYP41EB015897 · NIBIB · DUKE UNIVERSITY · PI JOHNSON, GEORGE ALLAN · 2012 to 2017
$7.4M
Ultra-Resolution Imaging of Brain Circuitry and its Development in Mental HealthR01MH096979 · NIMH · UNIVERSITY OF CALIFORNIA BERKELEY · PI LIU, CHUNLEI · 2013 to 2017
$1.8M
NIBIB NIH HHS P41 EB015897NIMH NIH HHS R01 MH096979
6 · The paper itself

Abstract

backgroundVarious studies by MRI exhibit that the corpus callosum (CC) is the most vulnerable to cuprizone administration, detecting the demyelination and remyelination process using different MRI parameters are, however, lacking. PURPOSE: To investigate the sensitivity of multiparametric MRI both in vivo and ex vivo for demyelination and remyelination. STUDY TYPE: Prospective. ANIMAL MODEL: A cuprizone mice model with an age-matched control group (n = 5), 4-week cuprizone exposure group followed by 9-week on a normal diet (n = 6), and a 13-week cuprizone exposure group (n = 6). FIELD STRENGTH/SEQUENCE: 3D gradient recalled echo, T ASSESSMENT: Quantification of DTI metrics, quantitative susceptibility mapping (QSM), and T STATISTICAL TESTS: Nonparametric permutation tests were used with a cluster-forming threshold as 3.09 (equivalent to P = 0.001), and the significant level as P = 0.05 with family-wise correction.

resultsIn vivo susceptibility values increased from -11.7 to -0.7 ppb (P < 0.001) in CC and from -13.7 to -5.1 ppb (P < 0.001) in the anterior commissure (AC) after the 13-week cuprizone exposure. Ex vivo susceptibility values increased from -25.4 to 7.4 ppb (P < 0.001) in CC and from -41.6 to -15.8 ppb (P < 0.001) in AC. Susceptibility values showed high variations to demyelination for in vivo studies (94.0% in CC, 62.8% in AC). Susceptibility values exhibited higher variations than radial diffusivity for ex vivo studies (129.1% vs. 28.3% in CC, 62.0% vs. 25.0% in AC). In addition to the differential susceptibility variations in different white matter tracts, intraregional demyelination variation was also present not only in CC but also in the AC area by voxel-based analysis. DATA

conclusionQSM is sensitive to the demyelination process of cuprizone exposure, which can be a complementary technique to conventional T LEVEL OF EVIDENCE: 2 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2019;50:1852-1865.

Indexed as

Disease Models, AnimalAnimalsCorpus CallosumCuprizoneDemyelinating DiseasesImaging, Three-DimensionalMiceMultiparametric Magnetic Resonance ImagingProspective StudiesRemyelinationSensitivity and SpecificityWhite MatterCuprizonecuprizonedemyelinationdiffusion tensor imaging (DTI)multiple sclerosis (MS)quantitative susceptibility mapping (QSM)remyelination

Identifiers

PMID31012202
PMCPMC6810724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.